NM_016734.3(PAX5):c.962C>G (p.Pro321Arg) AND not provided

This record was updated by the submitter. Please see the current version.

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 28, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003668534.1

Allele description

NM_016734.3(PAX5):c.962C>G (p.Pro321Arg)

Gene:

PAX5:paired box 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

9p13.2

Genomic location:

Preferred name:

NM_016734.3(PAX5):c.962C>G (p.Pro321Arg)

HGVS:

NC_000009.12:g.36882054G>C
NG_033894.1:g.157426C>G
NM_001280547.2:c.911-35125C>G
NM_001280548.2:c.962C>G
NM_001280549.2:c.781-35125C>G
NM_001280550.2:c.781-41418C>G
NM_001280551.2:c.586+41301C>G
NM_001280552.2:c.910+41301C>G
NM_001280553.2:c.833C>G
NM_001280554.2:c.833C>G
NM_001280555.2:c.713-35125C>G
NM_001280556.2:c.638C>G
NM_016734.3:c.962C>GMANE SELECT
NP_001267477.1:p.Pro321Arg
NP_001267482.1:p.Pro278Arg
NP_001267483.1:p.Pro278Arg
NP_001267485.1:p.Pro213Arg
NP_057953.1:p.Pro321Arg
LRG_1384t1:c.962C>G
LRG_1384:g.157426C>G
LRG_1384p1:p.Pro321Arg
NC_000009.11:g.36882051G>C
NR_103999.2:n.1069C>G
NR_104000.2:n.1126C>G

Protein change:

P213R

Molecular consequence:

NM_001280547.2:c.911-35125C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280549.2:c.781-35125C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280550.2:c.781-41418C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280551.2:c.586+41301C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280552.2:c.910+41301C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280555.2:c.713-35125C>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001280548.2:c.962C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001280553.2:c.833C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001280554.2:c.833C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001280556.2:c.638C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_016734.3:c.962C>G - missense variant - [Sequence Ontology: SO:0001583]
NR_103999.2:n.1069C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_104000.2:n.1126C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004395742	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 28, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004395742

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 28, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV004395742.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PAX5 protein function. This variant has not been reported in the literature in individuals affected with PAX5-related conditions. This variant is present in population databases (rs577863510, gnomAD 0.007%). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 321 of the PAX5 protein (p.Pro321Arg).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Feb 28, 2024

ClinVar

Relating variation to medicine